stockrowAptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
- Revenue
- +6.03%
- EPS
- −73.9%
- Free cash flow
- −16.9%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
Follow ATR
Alert me
AptarGroup, Inc. (ATR) Net income
AptarGroup, Inc.'s net income for fiscal 2025 was $392.5M, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $267.9M. Over the past ten years it has ranged from $194.8M (fiscal 2018) to $392.5M (fiscal 2025) — the current reading is the highest in ten years. Net income has risen for 3 consecutive fiscal years. AptarGroup, Inc. ranks 11th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $392.5M | 4.90% |
| FY2024 | $374.2M | 31.67% |
| FY2023 | $284.2M | 18.63% |
| FY2022 | $239.6M | (1.68%) |
| FY2021 | $243.6M | 13.80% |
| FY2020 | $214.1M | (11.62%) |
| FY2019 | $242.2M | 24.37% |
| FY2018 | $194.8M | (11.48%) |
| FY2017 | $220.0M | 7.02% |
| FY2016 | $205.6M | 3.17% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $32.8M | (62.71%) |
| Jun 2026 | $88.0M | 20.95% |
| Mar 2026 | $72.8M | (2.02%) |
| Dec 2025 | $74.3M | (41.90%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| COO The Cooper Companies, Inc. compare | $570.3M |
| ALGN Align Technology, Inc. compare | $413.6M |
| AVTR Avantor, Inc. compare | $337.2M |
| ATR AptarGroup, Inc. | $267.9M |
| SOLV Solventum Corporation compare | $156.0M |
| RGEN Repligen Corporation compare | −$11.8M |
| BLCO Bausch + Lomb Corporation compare | −$103.0M |
| BAX Baxter International Inc. compare | −$723.0M |
| TFX Teleflex Incorporated compare | −$1.0B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ATR
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement